All manuscripts submitted to Advances in Pharmacology and Therapeutics Journal (APTJ) undergo a rigorous, fair, and transparent peer-review process to ensure high scientific, ethical, and editorial standards. The journal follows a double-blind peer-review model.
After submission, each manuscript is evaluated by the Editorial Office and the Editor-in-Chief for:
relevance to the journal’s scope (pharmacology, therapeutics, drug discovery, clinical pharmacology, toxicology, and related fields),
scientific quality and novelty,
compliance with ethical guidelines (including COPE principles),
adherence to formatting instructions,
plagiarism check using advanced similarity-detection software.
Manuscripts that fail to meet the basic requirements may be rejected without external review.
Manuscripts that pass the initial screening are assigned to two independent expert reviewers under a double-blind model, ensuring that:
reviewers do not know the authors’ identities,
authors do not know the reviewers’ identities.
A third reviewer may be invited when evaluations are contradictory or inconclusive.
Reviewers assess each submission based on:
scientific validity, methodological rigor, and robustness of data,
originality and significance of findings in pharmacology or therapeutics,
relevance to clinical or translational applications,
clarity of presentation and quality of writing,
ethical compliance regarding human/animal research,
adequacy of citations and data transparency.
The reviewers recommend one of the following decisions:
Accept
Minor Revision
Major Revision
Reject
If revisions are requested, authors must submit:
a revised manuscript,
a detailed point-by-point response to reviewers.
Major revisions may undergo an additional round of peer review.
The final decision is made by the Editor-in-Chief or the designated Handling Editor, based on:
reviewer comments,
quality of revisions,
alignment with journal standards and editorial priorities.
Accepted manuscripts proceed to:
professional copyediting,
technical editing and typesetting,
author proofing,
online-first publication.
APTJ adheres strictly to:
COPE publishing ethics,
ICMJE authorship criteria,
standards for data integrity, transparency, and conflict-of-interest disclosure.
Misconduct such as plagiarism, data manipulation, or duplicate publication leads to immediate rejection or retraction.